2-Methoxycinnamaldehyde
CAT:
804-HY-W046353-01
Size:
100 mg
For Laboratory Research Only. Not for Clinical or Personal Use.
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


2-Methoxycinnamaldehyde
Description:
2-Methoxycinnamaldehyde (o-Methoxycinnamaldehyde) is a natural compound that can be isolated from Cinnamomum cassia. 2-Methoxycinnamaldehyde inhibits topoisomerase-I/II and NF-κB signaling pathway, causes mitochondrial dysfunction, induces lysosomal vesiculation, thereby leading to DNA damage and cell apoptosis. 2-Methoxycinnamaldehyde exhibits antitumor effects[1][2][3].Product Name Alternative:
O-MethoxycinnamaldehydeUNSPSC:
12352005Hazard Statement:
H315, H319, H335Target:
Apoptosis; Caspase; Mitochondrial Metabolism; NF-κB; TopoisomeraseType:
Natural ProductsRelated Pathways:
Apoptosis; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; NF-κBApplications:
Cancer-programmed cell deathField of Research:
CancerAssay Protocol:
https://www.medchemexpress.com/2-methoxycinnamaldehyde.htmlPurity:
98.95Solubility:
DMSO : 100 mg/mL (ultrasonic)Smiles:
O=C/C=C/C1=CC=CC=C1OCMolecular Formula:
C10H10O2Molecular Weight:
162.19Precautions:
H315, H319, H335References & Citations:
[1]Wong HY, et al. Cinnamomum verum Component 2-Methoxycinnamaldehyde: A Novel Anticancer Agent with Both Anti-Topoisomerase I and II Activities in Human Lung Adenocarcinoma A549 Cells In Vitro and In Vivo. Phytother Res. 2016 Feb;30 (2) :331-40.|[2]Liu YH, et al. Cinnamomum verum ingredient 2-methoxycinnamaldehyde: a new antiproliferative drug targeting topoisomerase I and II in human lung squamous cell carcinoma NCI-H520 cells. Eur J Cancer Prev. 2017 Jul;26 (4) :314-323.|[3]Jin YH, et al. 2-Methoxycinnamaldehyde inhibits the TNF-α-induced proliferation and migration of human aortic smooth muscle cells. Int J Mol Med. 2017 Jan;39 (1) :191-198.Shipping Conditions:
Blue IceStorage Conditions:
-20°C (Powder, stored under nitrogen)Scientific Category:
Natural ProductsClinical Information:
No Development ReportedCAS Number:
1504-74-1
